Patents by Inventor Charles Antoine Coupet

Charles Antoine Coupet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF IMMUNE DEPRESSION
    Publication number: 20230256057
    Abstract: The present invention is in the field of immunotherapy. The invention provides non-propagative viral vectors comprising a nucleic acid molecule encoding at least a polypeptide having an IL-7 activity, wherein said non-propagative viral vector is for use in the treatment of immune depression induced by sepsis, burn, trauma, major surgery, senescence and/or coronavirus.
    Type: Application
    Filed: July 13, 2021
    Publication date: August 17, 2023
    Applicant: Transgene
    Inventors: Geneviève INCHAUSPE, Perrine MARTIN, Stéphane LEUNG-THEUNG-LONG, Karine LELU-SANTOLARIA, Alexei EVLACHEV, Charles Antoine COUPET, Aurélie RAY, Clarisse DUBOIS
  • Mycobacterial antigen vaccine
    Patent number: 10357555
    Abstract: The present invention relates generally to immunogenic combinations comprising at least five antigens of a Mycobacterium species as well as fusion thereof and nucleic acid molecules encoding such combined antigens and fusion. The present invention also relates to nucleic acid molecules, vectors, host cells and compositions comprising or encoding said combinations of mycobacterial antigens and fusion polypeptides as well as to methods for recombinantly producing them. The present invention also relates to methods of using said combinations of mycobacterial antigens, fusion polypeptides, vectors, host cells, compositions particularly for inducing or stimulating an immune response against a Mycobacterium infection or any disease caused by or associated with a Mycobacterium infection.
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: July 23, 2019
    Assignee: TRANSGENE SA
    Inventors: Emmanuel Tupin, Romain Micol, Charles Antoine Coupet, Geneviève Inchaupse, Marie Gouanvic, Nathalie Silvestre, Jean-Baptiste Marchand, Cécile Beny
  • Mycobacterial Antigen Vaccine
    Publication number: 20150165014
    Abstract: The present invention relates generally to immunogenic combinations comprising at least five antigens of a Mycobacterium species as well as fusion thereof and nucleic acid molecules encoding such combined antigens and fusion. The present invention also relates to nucleic acid molecules, vectors, host cells and compositions comprising or encoding said combinations of mycobacterial antigens and fusion polypeptides as well as to methods for recombinantly producing them. The present invention also relates to methods of using said combinations of mycobacterial antigens, fusion polypeptides, vectors, host cells, compositions particularly for inducing or stimulating an immune response against a Mycobacterium infection or any disease caused by or associated with a Mycobacterium infection.
    Type: Application
    Filed: July 10, 2013
    Publication date: June 18, 2015
    Applicant: TRANSGENE SA
    Inventors: Emmanuel Tupin, Romain Micol, Charles Antoine Coupet, Geneviève Inchaupse, Marie Gouanvic, Nathalie Silvestre, Jean-Baptiste Marchand, Cécile Beny